Sumary of Top in rheumatology: Black box warning on JAK inhibitors, NIH study on COVID-19 boosters:
- Source: Adobe Stock Another top story was about a new trial launched by the NIH that will examine COVID-19 vaccine booster shots in patients with autoimmune disease.
- NIH opens study of COVID-19 vaccine booster in patients with autoimmune disease The NIH has launched a clinical trial to examine antibody responses to a COVID-19 vaccine booster dose in patients with autoimmune disease who failed to respond to the initial vaccine regimen.
- Dysfunctional red blood cells in children may be ‘root cause’ of lupus The presence of mature red blood cells that still contain mitochondria is associated with higher systemic lupus erythematosus disease activity, according to data published in Cell.
- IVIG boosts platelet counts in COVID-vaccine-induced thrombotic thrombocytopenia In a case study of three patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, starting intravenous immune globulin was linked to reduced antibody-induced platelet activation in serum, according to data.